你即將離開本站

並前往https://finance.yahoo.com/news/turning-point-therapeutics-reports-first-200500353.html

Turning Point Therapeutics Reports First-Quarter 2022 ...

... including updates from our repotrectinib and elzovantinib programs as well as a first look at our discovery program for KRAS G12D.”.

確定！ 回上一頁

查詢 「KRAS G12D」的人也找了：

  1. KRAS G12D inhibitor
    2.
  2. kras基因
    3.
  3. Sotorasib
    4.
  4. kras是什麼
    5.
  5. KRAS G12C
    6.
  6. KRAS mutation
    7.
  7. KRAS G12D lung cancer
    8.
  8. kras突變
    9.